Loading...
Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
BACKGROUND: While it is well known that teriparatide (TPTD) increases bone mineral density (BMD) in osteoporotic patients, it is unknown whether TPTD pretreatment affects BMD after denosumab (DMAb) therapy. METHODS: Fifty-seven patients in TPTD-pretreated group and 35 patients in DMAb-alone group ha...
Saved in:
| Published in: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5892610/ https://ncbi.nlm.nih.gov/pubmed/29662314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S154686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|